• KinATLAS
  • TranscriptoNET
  • PhosphoNET
  • OncoNET
  • KinaseNET
  • DrugKiNET
  • DrugProNET
  • KiNET-AM
  • Kinetica Online

Updated November 2019

Home | Kinexus | Contact | Credits

Nomenclature

Short Name:
PSKH2
Full Name:
Serine/threonine-protein kinase H2
Alias:
  • PSK-H2

Classification

Type:
Protein-serine/threonine kinase
Group:
CAMK
Family:
PSK
SubFamily:
NA
 
 

Specific Links

Entrez-Gene Entry: 85481
Entrez-Protein Entry: NP_149117
KinBASE Entry: PSKH2
Pfam Entry: Q96QS6
PhosphoNET Entry: Q96QS6
Phosphosite Plus Entry: 2123
UCSD-Nature Entry: A002439
UniProt Entry: Q96QS6

General Links

ClustalW2
GPS-Cuckoo
Human Protein Atlas
Kinase.com
Kinase Research
Kinasource
Kinomer
Netphorest
NetworKIN
Phosida
PhosphoElm
Protein Blast
ScanSite
String

Structure

Mol. Mass (Da):
43,027
# Amino Acids:
385
# mRNA Isoforms:
1
mRNA Isoforms:
43,027 Da (385 AA; Q96QS6)
4D Structure:
NA
1D Structure:
Retrieve Gene Sequence
Retrieve Full Protein Sequence
Retrieve Catalytic Domain Sequence
 
Subfamily Alignment
subfamily domain
 
Domain Distribution:
Start End Domain
63 320 Pkinase
 

Post-translation Modifications

For detailed information on phosphorylation of this kinase go to PhosphoNET
Myristoylated:
G2 (predicted).
Serine phosphorylated:

S356, S359, S362.
Threonine phosphorylated:

T84, T85.
Tyrosine phosphorylated:

Y63.
 

Distribution

Based on gene microarray analysis from the NCBI
Human Tissue Distribution
% Max Expression:

Mean Expression:

Number of Samples:

Standard Deviation:
% Max Expression:

Mean Expression:

Number of Samples:

Standard Deviation:
  • adipose
    15

    1299

    9

    1513

  • adrenal
    0.04

    3

    4

    1

  • bladder
    0.02

    2

    2

    2

  • brain
    0.4

    35

    28

    20

  • breast
    4

    311

    10

    214

  • cervix
    0.02

    2

    9

    2

  • colon
    0.08

    7

    13

    6

  • heart
    0.05

    4

    4

    1

  • intestine
    0.02

    2

    3

    1

  • kidney
    0.04

    3

    4

    1

  • liver
    0.1

    12

    4

    13

  • lung
    8

    655

    11

    624

  • lymphnode
    0.05

    4

    1

    0

  • ovary
    0.02

    2

    3

    1

  • pancreas
    0.07

    6

    3

    3

  • pituitary
    0.3

    26

    5

    5

  • prostate
    0.07

    6

    8

    5

  • salivarygland
    0.06

    5

    5

    5

  • skeletalmuscle"
    0.05

    4

    5

    2

  • skin
    4

    375

    26

    183

  • spinalcord
    0.05

    4

    5

    3

  • spleen
    0.05

    4

    4

    2

  • stomach
    0.2

    19

    1

    0

  • testis
    0.02

    2

    5

    1

  • thymus
    0.05

    4

    5

    3

  • thyroid
    7

    547

    20

    580

  • tonsil
    0.06

    5

    4

    5

  • trachea
    0.05

    4

    5

    5

  • uterus
    0.06

    5

    4

    5

  • reticulocytes"
    -

    -

    -

    -

  • t-lymphocytes
    6

    496

    12

    30

  • b-lymphocytes
    100

    8394

    11

    8677

  • neutrophils
    0.02

    2

    12

    0

  • macrophages
    8

    700

    26

    600

  • sperm
    2

    127

    22

    120

 

Evolution

Species Conservation
PhosphoNET % Identity:
PhosphoNET % Similarity:
Homologene %
Identity:
PhosphoNET % Identity:
PhosphoNET % Similarity:
Homologene %
Identity:
  • tableheader
    100

    100

    100
  • tableheader
    97.4

    98.6

    97
  • tableheader
    95

    97.1

    96
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    -
  • tableheader
    82.8

    89.8

    82.5
  • tableheader
    -

    -

    -
  • tableheader
    58.9

    73.1

    -
  • tableheader
    38.1

    55.5

    -
  • tableheader
    -

    -

    -
  • tableheader
    62

    74.2

    -
  • tableheader
    60.9

    74

    -
  • tableheader
    35

    54.8

    68
  • tableheader
    58.5

    73.4

    -
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    -
  • tableheader
    38.9

    59.7

    -
  • tableheader
    37.3

    59.5

    -
  • tableheader
    39.4

    52.5

    -
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    -
  • tableheader
    27.4

    39.7

    35
  • tableheader
    -

    -

    -
  • tableheader
    -

    -

    -
For a wider analysis go to PhosphoNET Evolution in PhosphoNET
 

Regulation

Activation:
NA
Inhibition:
NA
Synthesis:
NA
Degradation:
NA
 

Protein Kinase Specificity

Matrix of observed frequency (%) of amino acids in aligned protein substrate phosphosites

Kinections GIF
Matrix Type:
Predicted from the application of the Kinexus Kinase Substrate Predictor Version 2.0 algorithm, which was trained with over 10,000 kinase-protein substrate pairs and 8,000 kinase-peptide substrate pairs.
Domain #:
1
 

Disease Linkage

Gene Expression in Cancers:

The COSMIC website notes an up-regulated expression score for PSKH2 in diverse human cancers of 295, which is 0.6-fold of the average score of 462 for the human protein kinases. The down-regulated expression score of 0 for this protein kinase in human cancers was 100% lower than the average score of 60 for the human protein kinases.
Mutagenesis Experiments:

Insertional mutagenesis studies in mice have not yet revealed a role for this protein kinase in mouse cancer oncogenesis.
Mutation Rate in All Cancers:

Percent mutation rates per 100 amino acids length in human cancers: 0.13 % in 24777 diverse cancer specimens. This rate is 1.8-fold higher than the average rate of 0.075 % calculated for human protein kinases in general.
Mutation Rate in Specific Cancers:

Highest percent mutation rates per 100 amino acids length in human cancers: 0.81 % in 864 skin cancers tested; 0.47 % in 1270 large intestine cancers tested; 0.45 % in 1685 lung cancers tested; 0.35 % in 589 stomach cancers tested; 0.2 % in 1276 kidney cancers tested; 0.17 % in 603 endometrium cancers tested; 0.14 % in 548 urinary tract cancers tested; 0.11 % in 238 bone cancers tested; 0.1 % in 273 cervix cancers tested; 0.07 % in 710 oesophagus cancers tested; 0.07 % in 1512 liver cancers tested; 0.06 % in 942 upper aerodigestive tract cancers tested; 0.06 % in 1316 breast cancers tested; 0.05 % in 558 thyroid cancers tested; 0.04 % in 1459 pancreas cancers tested; 0.03 % in 881 prostate cancers tested; 0.03 % in 833 ovary cancers tested; 0.01 % in 2082 central nervous system cancers tested; 0.01 % in 2009 haematopoietic and lymphoid cancers tested.
Frequency of Mutated Sites:

Most frequent mutations with the number of reports indicated in brackets: G312D (9).
Comments:
No deletions, insertions or complex mutations are noted on the COSMIC website.
 
COSMIC Entry:
PSKH2
  • Home
  • Top of Page
Copyright 2019 Kinexus BioInformatics Corporation